Detalhe da pesquisa
1.
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.
PLoS One
; 18(4): e0284037, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37040387
2.
Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark.
Cancer Epidemiol
; 73: 101976, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34217914
3.
A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer.
Cancer Manag Res
; 11: 9469-9481, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31819612
4.
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review.
Lung Cancer
; 112: 200-215, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29191596
5.
Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non-Small Cell Lung Cancer.
Clin Cancer Res
; 23(14): 3585-3591, 2017 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28073845
6.
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy.
J Med Chem
; 60(7): 3187-3197, 2017 04 13.
Artigo
Inglês
| MEDLINE | ID: mdl-28374589
7.
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Diagn Pathol
; 11(1): 95, 2016 Oct 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27717372
8.
EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).
Am J Cancer Res
; 5(9): 2892-911, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26609494